[Drugs acting on D3 receptors in neuropsychiatric disorders: facts and prospects. Implication for schizophrenia and its treatment in the regulation of BDNF-dependence on D3 receptor expression].
Sokoloff
P
P
Centre de recherche Pierre Fabre, 81100 Castres, France.
Leriche
L
L
D019208:Brain-Derived Neurotrophic Factor / Q000187:drug effects* / Q000235:genetics*; D018691:Excitatory Amino Acid Antagonists / Q000008:administration & dosage / Q000494:pharmacology*; D006801:Humans; D010622:Phencyclidine / Q000008:administration & dosage / Q000494:pharmacology*; D050637:Receptors, Dopamine D3 / Q000187:drug effects* / Q000235:genetics*; D016194:Receptors, N-Methyl-D-Aspartate / Q000037:antagonists & inhibitors / Q000235:genetics; D012559:Schizophrenia / Q000188:drug therapy / Q000235:genetics / Q000503:physiopathology
D019208:Brain-Derived Neurotrophic Factor; D018691:Excitatory Amino Acid Antagonists; D050637:Receptors, Dopamine D3; D016194:Receptors, N-Methyl-D-Aspartate; D010622:Phencyclidine